Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA PANACEA BIOTECH ABBOTT INDIA/
PANACEA BIOTECH
 
P/E (TTM) x 50.0 -60.9 - View Chart
P/BV x 18.2 0.9 2,066.5% View Chart
Dividend Yield % 1.2 0.0 -  

Financials

 ABBOTT INDIA   PANACEA BIOTECH
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-23
PANACEA BIOTECH
Mar-23
ABBOTT INDIA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs22,482191 11,749.0%   
Low Rs16,156107 15,077.9%   
Sales per share (Unadj.) Rs2,517.075.1 3,351.9%  
Earnings per share (Unadj.) Rs446.8-5.5 -8,109.5%  
Cash flow per share (Unadj.) Rs479.70.9 54,633.9%  
Dividends per share (Unadj.) Rs325.000-  
Avg Dividend yield %1.70-  
Book value per share (Unadj.) Rs1,480.5137.7 1,074.9%  
Shares outstanding (eoy) m21.2561.25 34.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.72.0 386.2%   
Avg P/E ratio x43.2-27.1 -159.6%  
P/CF ratio (eoy) x40.3170.0 23.7%  
Price / Book Value ratio x13.01.1 1,204.1%  
Dividend payout %72.70-   
Avg Mkt Cap Rs m410,5139,142 4,490.6%   
No. of employees `000NANA-   
Total wages/salary Rs m5,6361,265 445.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,4874,599 1,162.9%  
Other income Rs m1,543517 298.6%   
Total revenues Rs m55,0305,116 1,075.6%   
Gross profit Rs m12,05547 25,637.8%  
Depreciation Rs m700391 178.8%   
Interest Rs m16044 360.4%   
Profit before tax Rs m12,738128 9,947.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,244466 696.9%   
Profit after tax Rs m9,494-337 -2,813.5%  
Gross profit margin %22.51.0 2,204.6%  
Effective tax rate %25.5363.5 7.0%   
Net profit margin %17.8-7.3 -241.9%  
BALANCE SHEET DATA
Current assets Rs m30,2515,623 538.0%   
Current liabilities Rs m12,0603,297 365.8%   
Net working cap to sales %34.050.6 67.3%  
Current ratio x2.51.7 147.1%  
Inventory Days Days8759 147.9%  
Debtors Days Days248 4.5%  
Net fixed assets Rs m15,1357,028 215.3%   
Share capital Rs m21361 346.9%   
"Free" reserves Rs m31,2488,375 373.1%   
Net worth Rs m31,4608,436 372.9%   
Long term debt Rs m0202 0.0%   
Total assets Rs m45,38612,712 357.0%  
Interest coverage x80.73.9 2,075.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.20.4 325.7%   
Return on assets %21.3-2.3 -922.6%  
Return on equity %30.2-4.0 -754.4%  
Return on capital %41.02.0 2,053.9%  
Exports to sales %0.443.3 1.0%   
Imports to sales %10.824.4 44.1%   
Exports (fob) Rs m2211,992 11.1%   
Imports (cif) Rs m5,7651,124 513.1%   
Fx inflow Rs m3101,992 15.6%   
Fx outflow Rs m5,8181,191 488.5%   
Net fx Rs m-5,508801 -687.3%   
CASH FLOW
From Operations Rs m8,934-4,225 -211.5%  
From Investments Rs m-1,4774,303 -34.3%  
From Financial Activity Rs m-6,387-184 3,476.4%  
Net Cashflow Rs m1,070-105 -1,018.9%  

Share Holding

Indian Promoters % 0.0 73.6 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 8.9 1.0 938.9%  
FIIs % 0.2 0.3 69.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 26.4 94.7%  
Shareholders   72,252 47,091 153.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Abbott India vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs Panacea Biotech Share Price Performance

Period Abbott India Panacea Biotech S&P BSE HEALTHCARE
1-Day 0.74% -1.74% 1.18%
1-Month -5.97% -20.01% -0.75%
1-Year 24.80% 11.75% 61.82%
3-Year CAGR 21.40% -12.26% 18.16%
5-Year CAGR 29.91% -9.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 325.0 per share. This amounted to a Dividend Payout ratio of 72.7%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Abbott India, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.